中文名称  磷酸化急性髓细胞1蛋白抗体说明书 

英文名称  Anti-phospho-RUNX1/AML1(Ser249)

别    名 RUNX1 (phospho-Ser249); p-RUNX1 (Ser249); RUNX1 (phospho S249); RUNX1 (phospho Ser249); Acute myeloid leukemia 1; Acute myeloid leukemia 1 protein; alpha subunit core binding factor; AML 1; AML1 EVI 1; Aml1 oncogene; AMLCR 1; AMLCR1; CBFA 2; CBFA2; Core binding factor alpha 2 subunit; Core binding factor runt domain alpha subunit 2; EVI 1; EVI1; HGNC; Oncogene AML 1; PEA2 alpha; PEBP2 alpha B; PEBP2A2; PEBP2aB; Polyomavirus enhancer binding protein 2 alpha B subunit; Run1; Runt related transcription factor 1; RUNX 1; SL3 3 enhancer factor 1 alpha B subunit; SL3/AKV core binding factor alpha B subunit; RUNX1_HUMAN.

产品属性：

磷酸化急性髓细胞1蛋白抗体说明书 浓    度  1mg/1ml

规 格  0.1ml/100μg

抗体来源  Rabbit

克隆类型   polyclonal

交叉反应   Human, Mouse, Rat, Dog, Pig, Cow, Rabbit, Guinea Pig

产品类型   一抗 磷酸化抗体  

研究领域     细胞生物 细胞凋亡

蛋白分子量  predicted molecular weight: 50kDa 

性    状   Lyophilized or Liquid

免 疫 原  KLH conjugated synthesised phosphopeptide derived from human RUNX1 around the phosphorylation site of Ser249 [QP(p-S)PP]

亚    型  IgG

纯化方法   affinity purified by Protein A

储 存 液   Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4

磷酸化急性髓细胞1蛋白抗体说明书 产品应用   WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500

（石蜡切片需做抗原修复） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存条件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

产品介绍 AML1/Runx1 binds DNA as a monomer and through the Runt domain. DNA binding is increased by heterodimerization with CBFB. Isoform AML1L can neither bind DNA nor heterodimerize and interferes with the transactivation activity of AML1/Runx1. CBF binds to the core site, 5'-PYGPYGGT-3', of a number of enhancers and promoters, including murine leukemia virus, polyomavirus enhancer, T cell receptor enhancers, LCK, IL3 and GMCSF promoters. The alpha subunit binds DNA and appears to have a role in the development of normal hematopoiesis. AML1/Runx1 is expressed in a wide variety of tissues and is expressed at the highest levels in thymus, bone marrow and peripheral blood. Defects in AML1/Runx1 are the cause of familial platelet disorder with associated myeloid malignancy, an autosomal dominant disease characterized by qualitative and quantitative platelet defects, and propensity to develop acute myelogenous leukemia.

Function : CBF binds to the core site, 5'-PYGPYGGT-3', of a number of enhancers and promoters, including murine leukemia virus, polyomavirus enhancer, T-cell receptor enhancers, LCK, IL-3 and GM-CSF promoters. The alpha subunit binds DNA and appears to have a role in the development of normal hematopoiesis. Isoform AML-1L interferes with the transactivation activity of RUNX1. Acts synergistically with ELF4 to transactivate the IL-3 promoter and with ELF2 to transactivate the mouse BLK promoter. Inhibits KAT6B-dependent transcriptional activation.

Subunit : Heterodimer with CBFB. RUNX1 binds DNA as a monomer and through the Runt domain. DNA-binding is increased by heterodimerization. Isoform AML-1L can neither bind DNA nor heterodimerize. Interacts with TLE1 and ALYREF/THOC4. Interacts with ELF1, ELF2 and SPI1. Interacts via its Runt domain with the ELF4 N-terminal region. Interaction with ELF2 isoform 2 (NERF-1a) may act to repress RUNX1-mediated transactivation. Interacts with KAT6A and KAT6B. Interacts with SUV39H1, leading to abrogation of transactivating and DNA-binding properties of RUNX1. Interacts with YAP1. Interacts with HIPK2 (By similarity). Interaction with CDK6 prevents myeloid differentiation, reducing its transcription transactivation activity.

Subcellular Location : Nucleus.

Tissue Specificity : Expressed in all tissues examined except brain and heart. Highest levels in thymus, bone marrow and peripheral blood.

Post-translational modifications : Phosphorylated in its C-terminus upon IL-6 treatment. Phosphorylation enhances interaction with KAT6A.

Methylated.

Phosphorylated in Ser-249 Thr-273 and Ser-276 by HIPK2 when associated with CBFB and DNA. This phosphorylation promotes subsequent EP300 phosphorylation.

DISEASE : Note=A chromosomal aberration involving RUNX1/AML1 is a cause of chronic myelogenous leukemia (CML). Translocation t(3;21)(q26;q22) with EAP or MECOM.

Note=A chromosomal aberration involving RUNX1/AML1 is found in childhood acute lymphoblastic leukemia (ALL). Translocation t(12;21)(p13;q22) with TEL. The translocation fuses the 3'-end of TEL to the alternate 5'-exon of AML-1H.

Note=A chromosomal aberration involving RUNX1 is found in acute leukemia. Translocation t(11,21)(q13;q22) that forms a MACROD1-RUNX1 fusion protein.

Defects in RUNX1 are the cause of familial platelet disorder with associated myeloid malignancy (FPDMM) [MIM:601399]. FPDMM is an autosomal dominant disease characterized by qualitative and quantitative platelet defects, and propensity to develop acute myelogenous leukemia.

Note=A chromosomal aberration involving RUNX1/AML1 is found in therapy-related myeloid malignancies. Translocation t(16;21)(q24;q22) that forms a RUNX1-CBFA2T3 fusion protein.

Note=A chromosomal aberration involving RUNX1/AML1 is a cause of chronic myelomonocytic leukemia. Inversion inv(21)(q21;q22) with USP16.

Similarity : Contains 1 Runt domain.

Database links : UniProtKB/Swiss-Prot: Q01196.3

实验流程：

全、新、优、品、好四大特点：

磷酸化急性髓细胞1蛋白抗体说明书 全：公司提供上万种产品，涵盖了生物试剂，elisa试剂盒，标准品，培养基，原装耗材，抗体、培养基、ATCC细胞等，基本上各种科研所需产品在我司都能找到。

新：产品更新速度较快，基本上每周都有新产品出现。

优：产品质量好，投诉比较少。

好：我公司具有优质的技术团队，产品一旦售出，实验过程中遇到困难可提供在线技术咨询。使您使用产品时没有任何的后顾之忧。

技术外包服务:

★磷酸化急性髓细胞1蛋白抗体说明书 分子生物学：质粒抽提、PCR、Q-PCR、RT-PCR、分子生物学：基因合成、引物合成、基因测序、载体构建等

★蛋白工程：原核、哺乳动物蛋白表达系统等

★病毒包装：腺病毒、慢病毒等

★抗体工程：磁珠分选、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等

★细胞工程：细胞表型分析(凋亡、增殖、周期、迁移、侵袭、修复、克隆形成)、细胞培养、细胞膜制备、稳定细胞株构建、细胞RNAi技术等等。

正在热销的相关产品：

GnRHR peptide 激素释放激素受体抗原Multi-class antibodies规格： 0.5mg

PPM1A PPM1A / PP2C-alpha 鼠单抗 (FITC) Human

Rhesus antibody Rh Phospho-CRMP2 (Thr514+Ser518) 磷酸化二氢嘧啶酶样2抗体 规格 0.1ml

Foline-Phenol(福林酚),2N 50ml/500ml 自产

ZFP36L1 英文名称： EGF应答因子1抗体抗体 0.2ml

DRGX 英文名称： 背根神经节同源蛋白DRGX抗体 0.2ml

PPM1A PPM1A / PP2C-alpha 鼠单抗 (FITC) Human

Anti-PTGEs/FITC 荧光素标记素E合成酶抗体IgGMulti-class antibodies规格： 0.2ml

THY (thyroglobulin,TG) 甲状腺球蛋白Multi-class antibodies规格： 10mg

胰岛素受体底物-4抗体 Anti-IRS-4 0.2ml

Goat anti-Mouse IgM whole serum 羊抗小鼠IgM抗血清 1ml

Ferritin Light Chain 英文名称： 铁蛋白轻链抗体 0.1ml

Rhesus antibody Rh phospho-PRKAB1(Ser182) 磷酸化腺苷单磷酸活化蛋白激酶β1抗体 规格 0.1ml

THY (thyroglobulin,TG) 甲状腺球蛋白Multi-class antibodies规格： 10mg

SLC25A20 英文名称： 线粒体二羧酸载体蛋白20抗体 0.1ml

EYA3 英文名称： EYA3蛋白抗体 0.2ml

神经丝蛋白抗体(人) Anti-AD7C-NTP/NTP/AF human 0.1ml

Anti-NHE1/RBITC 红色罗丹明标记氢通道蛋白抗体IgGMulti-class antibodies规格： 0.2ml

Rhesus antibody Rh Phospho-FGFR1 (Tyr307) 磷酸化碱性成纤维细胞生长因子受体1抗体 规格 0.1ml

cRaf/Raf1(c-raf 1) cRaf/Raf1抗原Multi-class antibodies规格： 0.5mg

其他细胞因子

JeKo-1 人套细胞细胞

IFNA4 Others Mouse 小鼠 IFNA4 / Ierferon alpha-4 人细胞裂解液 (阳性对照)

22RV1人细胞 Human prostate cancer 22RV1 cells 人

家猫肾细胞;CATK1

小鼠海马趾神经细胞(MH-h)(1×106) HCT116, 人结细胞 Human

CL-0350Hela S3(人细胞)5×106cells/瓶×2

EPHB2 Others Human 人 EphB2 / Hek5 人细胞裂解液 (阳性对照)

人总RNAHPF NA

Hs-578T细胞，人癌细胞 SD大鼠骨髓间充质干细胞,SDBMSC细胞 Hep-2, 人细胞系

NCI-H661(人大细胞细胞) 5×106cells/瓶×2

HDBEC Pellet 人皮肤内皮细胞团块(少年者) > 1 mio.cells 前脂肪细胞培养基PAM-prf

磷酸化急性髓细胞1蛋白抗体说明书 其他细胞因子

JeKo-1 人套细胞细胞

IFNA4 Others Mouse 小鼠 IFNA4 / Ierferon alpha-4 人细胞裂解液 (阳性对照)

22RV1人细胞 Human prostate cancer 22RV1 cells 人

家猫肾细胞;CATK1

小鼠海马趾神经细胞(MH-h)(1×106) HCT116, 人结细胞 Human